Rifampin-Resistant Tuberculosis in a Patient Receiving Rifabutin Prophylaxis
- 13 June 1996
- journal article
- case report
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 334 (24) , 1573-1576
- https://doi.org/10.1056/nejm199606133342404
Abstract
Drug-resistant tuberculosis has become a major public health problem in the United States.1,2 In 1979 less than 1 percent of tuberculosis isolates from untreated patients in New York City were resistant to rifampin, as compared with 9 percent in 1991.3 Rifampin-resistant tuberculosis is a serious threat because responses to therapy are more difficult to achieve and require longer courses of treatment.4-8Keywords
This publication has 30 references indexed in Scilit:
- Mapping and sequencing of mutations in the Escherichia colirpoB gene that lead to rifampicin resistancePublished by Elsevier ,2004
- Predictors and Outcome of Multidrug-Resistant TuberculosisClinical Infectious Diseases, 1995
- Improved Outcomes for Patients with Multidrug-Resistant TuberculosisClinical Infectious Diseases, 1995
- Eleven years of community-based directly observed therapy for tuberculosisPublished by American Medical Association (AMA) ,1995
- Mutation position and type of substitution in the β-subunit of the RNA polymerase influence in-vitro activity of rifamycins in rifampicin-resistant Mycobacterium tuberculosisJournal of Antimicrobial Chemotherapy, 1995
- Effectiveness of supervised, intermittent therapy for tuberculosis in HIV-infected patientsAIDS, 1994
- Nationwide survey of drug-resistant tuberculosis in the United StatesPublished by American Medical Association (AMA) ,1994
- Two Controlled Trials of Rifabutin Prophylaxis against Mycobacterium avium Complex Infection in AIDSNew England Journal of Medicine, 1993
- Treatment of Multidrug-Resistant TuberculosisNew England Journal of Medicine, 1993
- Detection of rifampicin-resistance mutations in Mycobacterium tuberculosisThe Lancet, 1993